Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 3/25/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Neil H. Bander M.D.

Wrong Dr. Neil H. Bander M.D.?

Professor - Tenure

Local Address: New York, New York, United States
Cornell University
159 Sapsucker Woods Road
Ithaca, New York 14850
United States

Company Description: Founded in 1865, Cornell is the federal land-grant institution of New York State, a private endowed university, a member of the Ivy League, and a partner of the...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • MD
44 Total References
Web References
Dr. Neil Bander, ...
www.adctherapeutics.com, 25 Feb 2014 [cached]
Dr. Neil Bander, Chairman
Dr. Neil H. Bander, MD is a physician-scientist trained in urological oncology and tumor immunology, both at Memorial Sloan-Kettering Cancer Center. Since joining the faculty of Cornell University Medical College (now Weill-Cornell Medical College) and New York-Presbyterian Hospital, he has directed both a laboratory effort and translational clinical research program to discover and clinically develop monoclonal antibodies for targeted cancer imaging and therapy.
Dr. Bander's team has the world's largest experience in antibody discovery and clinical development in urological cancers. His group developed the first series of monoclonal antibodies to prostate-specific membrane antigen (PSMA) that could target and bind viable prostate cancer cells. In part as a result of Dr. Bander's efforts, PSMA has become recognized as the most prostate-cancer specific cell surface antigen known. His team and collaborators have developed PET imaging agents as well as radiolabeled- and drug-conjugated antibodies that have entered phase 1 and 2 clinical trials now extending to a dozen leading academic medical centers in the
US. The lead radiolabeled antibody is slated for international phase 3 trials in the coming months. Dr. Bander has long-standing interests and activities in the antibody-drug conjugate field. Via joint efforts with multiple industry collaborators, Dr. Bander has direct experience with virtually every major drug-linker platform available. He lectures and writes frequently on the topic.
In addition to collaborates with multiple academic groups, Dr. Bander also serves as a consultant and Advisory Board member to several bio-pharmaceutical companies. He is a Joint Steering Committee member of the Pfizer-Weill/Cornell Center for Technological Innovation. Antibodies developed in his lab have been licensed to multiple bio-pharma companies for further development and commercialization.
Dr. Bander has authored approximately 175 peer-reviewed publications, and he is an inventor on approximately 100 US and foreign issued and pending patents. He has received several honors including the FC Valentine Fellowship from the NY Academy of Med, the Society of Surgical Oncology James Ewing Research Award, awards from the German and Japanese Urology Societies, the Prostate Cancer Foundation, and the Clarke Medal for Surgical Innovation from the Royal College of Surgeons (London).
UsTOO New York About Page
www.ustoonewyork.org, 7 Oct 2013 [cached]
NEIL BANDER, MD Chaus Professor of Urologic Oncology
Dr Neil H. Bander, Director ...
www.adctherapeutics.com, 15 July 2013 [cached]
Dr Neil H. Bander, Director of Urological Oncology Research at Weill Cornell Medical College from where the anti-PSMA antibody was licensed, said: "We have direct experience with virtually every antibody-drug conjugate platform currently available; none have produced the level of efficacy we have seen with ADC Therapeutics' PBD warheads - in vivo efficacy data from their PSMA-targeted ADC drug candidate are truly exciting, and we are excited to see this potentially breakthrough therapy translated into a clinic program as soon as possible."
...
We are pleased to have established this exclusive relationship with the outstanding team in Dr. Bander's laboratories at Weill-Cornell."
Day Two / World ADC by Hanson Wade
adc-summit.com, 16 Oct 2013 [cached]
Chair: Neil Bander, Professor, Weill Cornell Medical College
Cornell Urology - Physicians
www.cornellurology.com, 16 July 2011 [cached]
Dr. Neil Bander
...
Neil H. Bander, M.D.
Other People with the name "Bander":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.